CONDENSED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Operating activities
Net loss	$ (218,086)	$ (416,685)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	9,593	8,861
Provision for bad debts	1,058	217
Amortization of deferred financing costs included in interest expense		63
Compensation expense on stock-based arrangements with employees and consultants	39,305	51,478
Changes in operating assets and liabilities:
Accounts receivable	(180,976)	(8,011)
Inventories	(9,369)	(26,869)
(Increase) / decrease in prepaid expenses and other current assets	2,223	(26,638)
Accounts payable	46,186	39,754
Deferred compensation	40,325	30,092
Accrued liabilities	9,247	28,248
Net cash used in operating activities	(260,494)	(319,490)
Investing activities
Purchases of property and equipment	(9,999)	(4,480)
Capitalized patent costs	(14,017)	(14,292)
Net cash used in investing activities	(24,016)	(18,772)
Financing activities
Proceeds from issuance of notes payable to stockholders	250,050	375,080
Payment of capital lease obligations	(1,958)	(1,799)
Net cash provided by financing activities	248,092	373,281
Net Increase (decrease) in cash and cash equivalents	(36,418)	35,019
Cash and cash equivalents at beginning of period	161,503	114,512
Cash and cash equivalents at end of period	125,085	149,531
Supplemental cash flow information:
Cash paid for interest	55,629	46,140
Common Stock issued in satisfaction of note payable		$ 150,000